Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines Announces Prominent Oncologist Dr. Scott Kopetz Joins its Scientific Advisory Board
21 juin 2022 08h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., June 21, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines to Present at the Jefferies Healthcare Conference
02 juin 2022 16h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., June 02, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines Announces Oral Presentation on Dual-Acting Inhibitors of the Active and Inactive Forms of KRAS G12C at the American Association for Cancer Research (AACR) Annual Meeting
09 mars 2022 08h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., March 09, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines Announces the Appointment of Monique Bobadilla as Chief People and Culture Officer
08 mars 2022 08h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., March 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines Announces Renowned Physician Scientist Piro Lito, M.D., Ph.D., Joins Scientific Advisory Board
08 févr. 2022 08h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthrough therapies against...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines Announces Advancement of First Program Under Global Partnership with AbbVie
10 janv. 2022 07h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines to Present at the 40th Annual J.P. Morgan Healthcare Conference
05 janv. 2022 08h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference
09 déc. 2021 08h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Dec. 09, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines Announces the Appointment of Marguerite Hutchinson, J.D., as Chief Business Officer
17 nov. 2021 08h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Nov. 17, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...
Frontier Primary_Logo_Full_Color_RBG@2x.png
Frontier Medicines to Present at Two Upcoming Investor Conferences in November
10 nov. 2021 16h00 HE | Frontier Medicines
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise...